Medifast Inc (MED): R&D Expense
$4.30M
Year ended 2025-12-31
-1.5%
3-year compound annual growth
+9.0%
5-year compound annual growth
+9.1%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.30M | -6.5% | 2026-02-17, From 2025-01-01 |
| 2024-12-31 | $4.60M | 0.0% | 2026-02-17, From 2024-01-01 |
| 2023-12-31 | $4.60M | +2.2% | 2026-02-17, From 2023-01-01 |
| 2022-12-31 | $4.50M | +2.3% | 2025-02-18, From 2022-01-01 |
| 2021-12-31 | $4.40M | +57.1% | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | $2.80M | +3.7% | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | $2.70M | +22.7% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | $2.20M | +46.7% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $1.50M | -25.0% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $2.00M | +11.1% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $1.80M | +38.5% | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | $1.30M | n/a | 2017-03-16, From 2014-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Medifast Inc (MED) | 2025-12-31 | $4.30M | -6.5% |
| McCormick & Co Inc (MKC) | 2025-11-30 | $106.10M | +3.1% |
Compare MED, MKC side by side · Screen every company in Miscellaneous Food Preparations & Kindred Products ↗